Company intelligence / Profile preview

Blu Biotech

San Diego, California, USA

Ownership: Private
Development stage: Other

Overview

Blu Biotech is a medical technology company specializing in non-invasive diagnostic solutions through advanced breath analysis. The company's proprietary Blu-Breath platform identifies specific volatile organic compounds (VOCs) that serve as biomarkers for various diseases. Their portfolio includes rapid screening tests for COVID-19, as well as ongoing research into early detection for lung and breast cancers. Blu Biotech's technology is designed for point-of-care use, offering a painless and efficient alternative to traditional blood or tissue-based diagnostics.

Therapeutic areas: Infectious DiseasesOncologyEndocrinologyGastroenterology
Modalities: DeviceDiagnostic
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Blu Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blu Biotech.

Explore the full profile